Adiponectin Oligomers in Human Serum during Acute and Chronic Exercise: Relation to Lipid Metabolism and Insulin Sensitivity

 

 Buy Article Permissions and Reprints

Abstract

Beneficial effects of physical exercise include improved insulin sensitivity, which may be affected by a modulated release of adiponectin, which is exclusively synthesized in white adipose tissue and mediates insulin sensitivity. Adiponectin circulates in three different oligomers, which also have a distinct biological function. We therefore aimed to investigate the distribution of adiponectin oligomers in human serum in relation to physical activity. Thirty-eight lean and healthy individuals were investigated. Seven healthy women and 8 healthy men volunteered to investigate the effect of chronic exercise, at 3 different time points with different training intensities. These individuals were all highly trained and were compared to a control group with low physical activity (n = 15). For studying acute exercise effects, 8 healthy men participated in a bicycle test. Adiponectin was determined by ELISA, oligomers were detected by non-denaturating western blot. Total adiponectin and oligomers were unchanged by acute exercise. LDL cholesterol was significantly lower in the chronic exercise group (p = 0.03). Total adiponectin levels and oligomers were not different between these two groups and were unaltered by different training intensities. However, total adiponectin and specifically HMW oligomers correlated with HDL cholesterol (r = 0.459; p = 0.009). We conclude that acute and chronic exercise does not directly affect circulating adiponectin or oligomer distribution in lean and healthy individuals. Whether such regulation is relevant in individuals with a metabolic disorder remains to be determined. However, our data suggest that adiponectin oligomers have distinct physiological functions in vivo, and specifically HMW adiponectin is closely correlated with HDL cholesterol.

References

• 1 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.  Nat Med. 2001;  7 947-953
  CrossrefPubMedGoogle Scholar
• 2 Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert M O, Mohlig M, Pfeiffer A F, Spranger J. Changes of adiponectin oligomer composition by moderate weight reduction.  Diabetes. 2005;  54 2712-2719
  CrossrefPubMedGoogle Scholar
• 3 Byberg L, Zethelius B, McKeigue P M, Lithell H O. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors.  Diabetologia. 2001;  44 2134-2139
  CrossrefPubMedGoogle Scholar
• 4 Chan D C, Watts G F, Ng T W, Uchida Y, Sakai N, Yamashita S, Barrett P H. adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.  Clin Chem. 2005;  51 578-585
  CrossrefPubMedGoogle Scholar
• 5 Eriksson K F, Lindgarde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise.  Diabetologia. 1998;  41 1010-1016
  CrossrefPubMedGoogle Scholar
• 6 Ferguson M A, White L J, McCoy S, Kim H W, Petty T, Wilsey J. Plasma adiponectin response to acute exercise in healthy subjects.  Eur J Appl Physiol. 2004;  91 324-329
  CrossrefPubMedGoogle Scholar
• 7 Havel P J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.  Curr Opin Lipidol. 2002;  13 51-59
  CrossrefPubMedGoogle Scholar
• 8 Helmrich S P, Ragland D R, Leung R W, Paffenbarger Jr R S. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.  N Engl J Med. 1991;  325 147-152
  CrossrefPubMedGoogle Scholar
• 9 Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity.  J Biol Chem. 1996;  271 10697-10703
  CrossrefPubMedGoogle Scholar
• 10 Hulver M W, Zheng D, Tanner C J, Houmard J A, Kraus W E, Slentz C A, Sinha M K, Pories W J, MacDonald K G, Dohm G L. Adiponectin is not altered with exercise training despite enhanced insulin action.  Am J Physiol. 2002;  283 E861-E865
  PubMedGoogle Scholar
• 11 Jurimae J, Purge P, Jurimae T. Adiponectin is altered after maximal exercise in highly trained male rowers.  Eur J Appl Physiol. 2005;  93 502-505
  PubMedGoogle Scholar
• 12 Kirwan J P, del Aguila L F. Insulin signalling, exercise and cellular integrity.  Biochem Soc Trans. 2003;  31 1281-1285
  PubMedGoogle Scholar
• 13 Kraemer R R, Aboudehen K S, Carruth A K, Durand R T, Acevedo E O, Hebert E P, Johnson L G, Castracane V D. Adiponectin responses to continuous and progressively intense intermittent exercise.  Med Sci Sports Exerc. 2003;  35 1320-1325
  CrossrefPubMedGoogle Scholar
• 15 Kriketos A D, Gan S K, Poynten A M, Furler S M, Chisholm D J, Campbell L V. Exercise increases adiponectin levels and insulin sensitivity in humans.  Diabetes Care. 2004;  27 629-630
  CrossrefPubMedGoogle Scholar
• 16 Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation.  J Biol Chem. 2002;  277 25863-25866
  CrossrefPubMedGoogle Scholar
• 17 Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).  Biochem Biophys Res Commun. 1996;  221 286-289
  CrossrefPubMedGoogle Scholar
• 18 Nakano Y, Tobe T, Choi-Miura N H, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.  J Biochem. 1996;  120 803-812
  CrossrefPubMedGoogle Scholar
• 19 Pajvani U B, Hawkins M, Combs T P, Rajala M W, Doebber T, Berger J P, Wagner J A, Wu M, Knopps A, Xiang A H, Utzschneider K M, Kahn S E, Olefsky J M, Buchanan T A, Scherer P E. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.  J Biol Chem. 2004;  279 12152-12162
  CrossrefPubMedGoogle Scholar
• 20 Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to C1q, produced exclusively in adipocytes.  J Biol Chem. 1995;  270 26746-26749
  CrossrefPubMedGoogle Scholar
• 21 Schulze M B, Shai I, Rimm E B, Li T, Rifai N, Hu F B. Adiponectin and future coronary heart disease events among men with type 2 diabetes.  Diabetes. 2005;  54 534-539
  CrossrefPubMedGoogle Scholar
• 22 Shapiro L, Scherer P E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor.  Curr Biol. 1998;  8 335-338
  CrossrefPubMedGoogle Scholar
• 23 Thompson P D, Crouse S F, Goodpaster B, Kelley D, Moyna N, Pescatello L. The acute versus the chronic response to exercise.  Med Sci Sports Exerc. 2001;  33 S438-S445
  CrossrefPubMedGoogle Scholar
• 24 Tomas E, Kelly M, Xiang X, Tsao T S, Keller C, Keller P, Luo Z, Lodish H, Saha A K, Unger R, Ruderman N B. Metabolic and hormonal interactions between muscle and adipose tissue.  Proc Nutr Soc. 2004;  63 381-385
  CrossrefPubMedGoogle Scholar
• 25 Tonelli J, Li W, Kishore P, Pajvani U B, Kwon E, Weaver C, Scherer P E, Hawkins M. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.  Diabetes. 2004;  53 1621-1629
  CrossrefPubMedGoogle Scholar
• 26 Tsao T S, Murrey H E, Hug C, Lee D H, Lodish H F. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).  J Biol Chem. 2002;  277 29359-29362
  CrossrefPubMedGoogle Scholar
• 27 Tsao T S, Tomas E, Murrey H E, Hug C, Lee D H, Ruderman N B, Heuser J E, Lodish H F. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways.  J Biol Chem. 2003;  278 50810-50817
  CrossrefPubMedGoogle Scholar
• 28 Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.  J Biol Chem. 2003;  278 40352-40363
  CrossrefPubMedGoogle Scholar
• 29 Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.  J Clin Endocrinol Metab. 2001;  86 1930-1935
  CrossrefPubMedGoogle Scholar
• 30 Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno N H, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.  Nature. 2003;  423 762-769
  CrossrefPubMedGoogle Scholar
• 31 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn B B, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.  Nat Med. 2002;  8 1288-1295
  CrossrefPubMedGoogle Scholar
• 32 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
  CrossrefPubMedGoogle Scholar
• 33 Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.  Blood. 2000;  96 1723-1732
  PubMedGoogle Scholar
• 34 Yokoyama H, Emoto M, Araki T, Fujiwara S, Motoyama K, Morioka T, Koyama H, Shoji T, Okuno Y, Nishizawa Y. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes.  Diabetes Care. 2004;  27 1756-1758
  PubMedGoogle Scholar
• 35 Yuan M, Konstantopoulos N, Lee J, Hansen L, Li Z W, Karin M, Shoelson S E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.  Science. 2001;  293 1673-1677
  CrossrefPubMedGoogle Scholar
• 36 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue.  Nature. 1994;  372 425-432
  CrossrefPubMedGoogle Scholar

M.D. Joachim Spranger

Department of Clinical Nutrition
German Institute of Human Nutrition Potsdam

Arthur-Scheunert-Allee 114 - 116

14558 Nuthetal

Germany

Phone: + 49 33 20 08 87 89

Fax: + 49 33 20 08 87 77

Email: spranger@mail.dife.de